×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [51]
内容类型
期刊论文 [45]
会议论文 [6]
发表日期
2019 [5]
2018 [7]
2017 [8]
2016 [5]
2015 [8]
2014 [9]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共51条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer
期刊论文
2019, 卷号: 12, 期号: 1, 页码: 97
作者:
Xiong Guangbing
;
Liu Chang
;
Yang Gang
;
Feng Mengyu
;
Xu Jianwei
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/01/03
Chemoresistance
GSTM3TV2
Pancreatic cancer
Prognosis
ceRNA
lncRNA
Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era
期刊论文
2019, 页码: 1-10
作者:
Qi Fei
;
Chen Bo
;
Wang Jingjing
;
Lin Xinyi
;
Qi Shunan
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2020/01/03
Extranodal NK/T-cell lymphoma
chemotherapy
radiotherapy
treatment sequence
Novel discoveries targeting gemcitabine-based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
期刊论文
2019
作者:
Luo Wenhao
;
Yang Gang
;
Qiu Jiangdong
;
Luan Jingyang
;
Zhang Ying
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
chemistry
drug therapy
metabolism
pancreatic cancer
prevention
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China
期刊论文
2019, 卷号: 98, 期号: 1, 页码: 143-150
作者:
Zhang, Yan
;
Zhang, Wei
;
Li, Jian
;
Duan, Minghui
;
Han, Bing
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/01/03
Peripheral T cell lymphoma
GDP
MTX
Pegaspargase
Overall response rate
Overall survival
WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer
期刊论文
2019, 卷号: 451, 页码: 48-57
作者:
Li, Bing-Qi
;
Liang, Zhi-Yong
;
Seery, Samuel
;
Liu, Qiao-Fei
;
You, Lei
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
WTAP
Fak
PC
Migration/invasion
Chemo-sensitivity
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
期刊论文
2018, 卷号: 19, 期号: 10, 页码: 1338-1350
作者:
Fang, Wenfeng
;
Yang, Yunpeng
;
Ma, Yuxiang
;
Hong, Shaodong
;
Lin, Lizhu
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Clinical efficacy of bevacizumab combined with gemcitabine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer
期刊论文
2018, 卷号: 23, 期号: 5, 页码: 1402-1406
作者:
Duan, Jianchun
;
Yang, Zhenhua
;
Liu, Dingyuan
;
Zhang, Zhen
;
Shi, Yunfei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
advanced non-small cell lung cancer
bevacizumab
survival rate
clinical effect
GP chemotherapy
Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study
期刊论文
2018, 卷号: 102, 期号: 1, 页码: 61-70
作者:
Qi, Fei
;
Wang, Wei-Hu
;
He, Xiao-Hui
;
Chen, Bo
;
Gui, Lin
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
期刊论文
2018, 卷号: 12, 期号: 12, 页码: 2147-2164
作者:
You, Lei
;
Wang, Huanyu
;
Yang, Gang
;
Zhao, Fangyu
;
Zhang, Jingcheng
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2020/01/03
gemcitabine chemotherapy
miRNA processing
pancreatic cancer
PVT1
Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine
期刊论文
2018, 卷号: 8, 期号: 12, 页码: 3366-3379
作者:
Huang, Xudong
;
Zheng, Jian
;
Li, Jun
;
Che, Xu
;
Tan, Wenle
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
pancreatic cancer
BACH1
HO-1
genetic variation
survival
©版权所有 ©2017 CSpace - Powered by
CSpace